by Team Small News | Apr 28, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s Laboratories has expanded its partnership with Sanofi Healthcare to introduce a novel drug, Beyfortus, for the prevention of lower respiratory tract disease (LRTD) in newborns and infants. Beyfortus contains the monoclonal antibody nirsevimab and is... by Team Small News | Apr 10, 2025 | Dr Reddy's, Pharma
Hyderabad-based pharmaceutical company, Dr. Reddy’s Laboratories Ltd, has partnered with US-based enterprise technology provider, Kyndryl, to transform its IT operations across all locations, including manufacturing plants, international sites, datacenters,... by Team Small News | Apr 6, 2025 | Dr Reddy's, Pharma
Dr Reddy’s Laboratories Limited, a pharmaceutical company, has received a showcause notice from the Income Tax Department, demanding a massive amount of over Rs 2,395 crore. The notice is related to the merger of Dr Reddy’s Holdings Limited (DRHL) with the... by Team Small News | Apr 2, 2025 | Dr Reddy's, Pharma
The former Dr. Reddy’s Laboratories pharmaceutical manufacturing site in Shreveport, Louisiana, is now up for sale. The 56-acre property, which was once home to 107 employees, was sold to Jaguar Labs Holdings, LLC, an affiliate of Ten Oaks Group. Realtor Chris... by Team Small News | Mar 29, 2025 | Dr Reddy's, Pharma
Dr. Reddy’s Laboratories, an Indian drugmaker, has secured regional rights to two biosimilars developed by Bio-Thera, a Chinese biotech company. The agreement grants Dr. Reddy’s the right to develop, manufacture, and market the biosimilars, which are... by Team Small News | Mar 29, 2025 | Dr Reddy's, Pharma
According to a recent article from Scrip, Dr. Reddy’s Laboratories has secured regional rights to a pair of biosimilars from Bio-Thera, a Chinese biotech company. The agreement grants Dr. Reddy’s the rights to commercialize Bio-Thera’s pegfedimondas...